Literature DB >> 20659269

The value of correcting values: influence and importance of correcting TTO scores for time preference.

Arthur E Attema1, Werner B F Brouwer.   

Abstract

OBJECTIVES: Quality-adjusted life year (QALY) values measured by means of the time tradeoff (TTO) method are often used in economic evaluations. However, these values are mostly not corrected for time preference, i.e., a lower valuation being attached to later life years than to earlier life years, and therefore may underestimate the true QALY weights. Moreover, the magnitude of the underestimation depends on the severity of the health state and the horizon chosen in the TTO method. Hence, we cannot just add a constant component to all existing QALY tariffs. In this study, we estimated the value of correcting TTO scores. We showed the possible consequences for health policymaking when we correct TTO scores for time preference, thereby taking into account severity and horizon.
METHODS: We employed the results obtained using a nonparametric time preference elicitation method. We made use of experimental time preference data, in order to better represent individuals' time preferences.
RESULTS: Our results demonstrate that correcting for time preference does not result in one clear influence on the QALY gains from health changes. When considering these changes in the context of cost-utility ratios, the proportional change in the QALY gain is crucial.
CONCLUSIONS: Correcting TTO scores has a moderate, yet nonnegligible influence on outcomes. We conclude that correcting TTO scores for time preference is feasible and influential, so that there can be a substantial value of correcting values for time preference.
© 2010, International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Mesh:

Year:  2010        PMID: 20659269     DOI: 10.1111/j.1524-4733.2010.00773.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  11 in total

1.  Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation.

Authors:  Liv A Augestad; Kim Rand-Hendriksen; Knut Stavem; Ivar Sønbø Kristiansen
Journal:  Qual Life Res       Date:  2012-06-08       Impact factor: 4.147

2.  What should we know about the person behind a TTO?

Authors:  Floortje van Nooten; Jan Busschbach; Michel van Agthoven; Job van Exel; Werner Brouwer
Journal:  Eur J Health Econ       Date:  2018-12

3.  A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots.

Authors:  Elahe Khorasani; Majid Davari; Abbas Kebriaeezadeh; Farshad Fatemi; Ali Akbari Sari; Vida Varahrami
Journal:  Eur J Health Econ       Date:  2022-03-02

4.  Health state utilities for migraine based on attack frequency: a time trade-off study.

Authors:  Fanni Rencz; Valentin Brodszky; Márta Péntek; Dániel Bereczki; László Gulácsi
Journal:  Neurol Sci       Date:  2014-08-10       Impact factor: 3.307

5.  Cost-utility analysis: current methodological issues and future perspectives.

Authors:  Mark J C Nuijten; Dominique J Dubois
Journal:  Front Pharmacol       Date:  2011-06-08       Impact factor: 5.810

6.  Community-based values for 2009 pandemic influenza A H1N1 illnesses and vaccination-related adverse events.

Authors:  Tara A Lavelle; Martin I Meltzer; Achamyeleh Gebremariam; Kara Lamarand; Anthony E Fiore; Lisa A Prosser
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

7.  Time trade-off: one methodology, different methods.

Authors:  Arthur E Attema; Yvette Edelaar-Peeters; Matthijs M Versteegh; Elly A Stolk
Journal:  Eur J Health Econ       Date:  2013-07

8.  Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries.

Authors:  Marc Evans; Kamlesh Khunti; Muhammad Mamdani; Claus B Galbo-Jørgensen; Jens Gundgaard; Mette Bøgelund; Stewart Harris
Journal:  Health Qual Life Outcomes       Date:  2013-06-03       Impact factor: 3.186

Review 9.  Discounting in Economic Evaluations.

Authors:  Arthur E Attema; Werner B F Brouwer; Karl Claxton
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

10.  Health state utilities for infertility and subfertility.

Authors:  Marieke Krol; Annemiek Nap; Renée Michels; Christiaan Veraart; Lucas Goossens
Journal:  Reprod Health       Date:  2019-05-03       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.